Development of treatments for sarcopenia: new challenges, opportunities and perspectives
Leo Westbury, Elizabeth M. Curtis, Ewa Balkowiec-Iskra, Antonio Cherubini, Mario Miguel Coelho da Silva Rosa, Paolo Foggi, Yury Kiselev, Andrea Laslop, Sif Ormarsdóttir, Maria Concepcion Prieto Yerro, Carla Torre, Katarina Vucic, Majed Alokail, Ali Al-Samil, Gulistan Bahat, Mario Barbagallo, Jürgen M. Bauer, Charlotte Beaudart, Angie Botto-van Bemden, Olivier Bruyère, Nansa Burlet, Etienne Cavalier, Alfonso J. Cruz-Jentoft, Patrizia D’Amelio, Sandra De Breucker, Gustavo Duque, Roger A. Fielding, Nature Reviews Rheumatology
· Springer Nature
· 2026-11-16
· DOI: 10.1038/s41584-026-01457-4
Аннотация
Nature Reviews Rheumatology, Published online: 16 November 2026; doi:10.1038/s41584-026-01457-4 This Perspective presents contemporary perspectives on advances and challenges in the development of pharmacological interventions for sarcopenia, including discussion of the evolving definition of sarcopenia, the changing regulatory landscape and considerations for the design of clinical trials.
Leo Westbury, Elizabeth M. Curtis, Ewa Balkowiec-Iskra, Antonio Cherubini, Mario Miguel Coelho da Silva Rosa, Paolo Foggi et al. Development of treatments for sarcopenia: new challenges, opportunities and perspectives. // Nature Reviews Rheumatology. – 2026. – DOI: 10.1038/s41584-026-01457-4. – URL: https://www.nature.com/articles/s41584-026-01457-4
Leo Westbury, Elizabeth M. Curtis, Ewa Balkowiec-Iskra, Antonio Cherubini, Mario Miguel Coelho da Silva Rosa, Paolo Foggi, Yury Kiselev, Andrea Laslop, Sif Ormarsdóttir, Maria Concepcion Prieto Yerro, Carla Torre, Katarina Vucic, Majed Alokail, Ali Al-Samil, Gulistan Bahat, Mario Barbagallo, Jürgen M. Bauer, Charlotte Beaudart, Angie Botto-van Bemden, Olivier Bruyère, Nansa Burlet, Etienne Cavalier, Alfonso J. Cruz-Jentoft, Patrizia D’Amelio, Sandra De Breucker, Gustavo Duque, & Roger A. Fielding (2026). Development of treatments for sarcopenia: new challenges, opportunities and perspectives. Nature Reviews Rheumatology. https://doi.org/10.1038/s41584-026-01457-4
Leo Westbury, et al. “Development of treatments for sarcopenia: new challenges, opportunities and perspectives.” Nature Reviews Rheumatology, 2026. doi:10.1038/s41584-026-01457-4.
@article{Westbury2026,
title = {Development of treatments for sarcopenia: new challenges, opportunities and perspectives},
author = {Westbury, Leo and Curtis, Elizabeth M. and Balkowiec-Iskra, Ewa and Cherubini, Antonio and Rosa, Mario Miguel Coelho da Silva and Foggi, Paolo and Kiselev, Yury and Laslop, Andrea and Ormarsdóttir, Sif and Yerro, Maria Concepcion Prieto and Torre, Carla and Vucic, Katarina and Alokail, Majed and Al-Samil, Ali and Bahat, Gulistan and Barbagallo, Mario and Bauer, Jürgen M. and Beaudart, Charlotte and Bemden, Angie Botto-van and Bruyère, Olivier and Burlet, Nansa and Cavalier, Etienne and Cruz-Jentoft, Alfonso J. and D’Amelio, Patrizia and Breucker, Sandra De and Duque, Gustavo and Fielding, Roger A.},
journal = {Nature Reviews Rheumatology},
year = {2026},
doi = {10.1038/s41584-026-01457-4},
url = {https://www.nature.com/articles/s41584-026-01457-4}
}
Objective Black patients with systemic sclerosis (scleroderma) have more severe disease than White patients. We investigated whether racial differences in therapeutic responses to mycophenolate mofetil (MMF) could explain this...